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Cytotoxic T lymphocytes (CTLs) have been suggested to play an important role in
controlling human immunodeficiency virus (HIV-1 or simply HIV) infection. HIV, due to
its high mutation rate, can evade recognition of T cell responses by generating escape
variants that cannot be recognized by HIV-specific CTLs. Although HIV escape from CTL
responses has been well documented, factors contributing to the timing and the rate of
viral escape from T cells have not been fully elucidated. Fitness costs associated with
escape and magnitude of the epitope-specific T cell response are generally considered
to be the key in determining timing of HIV escape. Several previous analyses generally
ignored the kinetics of T cell responses in predicting viral escape by either considering
constant or maximal T cell response; several studies also considered escape from
different T cell responses to be independent. Here, we focus our analysis on data from
two patients from a recent study with relatively frequent measurements of both virus
sequences and HIV-specific T cell response to determine impact of CTL kinetics on viral
escape. In contrast with our expectation, we found that including temporal dynamics
of epitope-specific T cell response did not improve the quality of fit of different models
to escape data. We also found that for well-sampled escape data, the estimates of the
model parameters including T cell killing efficacy did not strongly depend on the underlying
model for escapes: models assuming independent, sequential, or concurrent escapes
from multiple CTL responses gave similar estimates for CTL killing efficacy. Interestingly,
the model assuming sequential escapes (i.e., escapes occurring along a defined pathway)
was unable to accurately describe data on escapes occurring rapidly within a shorttime window, suggesting that some of model assumptions must be violated for such
escapes. Our results thus suggest that the current sparse measurements of temporal CTL
dynamics in blood bear little quantitative information to improve predictions of HIV escape
kinetics. More frequent measurements using more sensitive techniques and sampling
in secondary lymphoid tissues may allow to better understand whether and how CTL
kinetics impacts viral escape.
Keywords: HIV, CTL escape, multiple responses, mathematical model, model fitting, likelihood

Abbreviations: CTL, cytotoxic T lymphocyte; HIV, human immunodeficiency virus; SIV, simian immunodeficiency virus.
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simultaneously, thus allowing for co-existence of multiple escape
variants (i.e., escapes could occur along multiple alternative pathways). Interestingly, we found that for well-sampled data on virus
evolution, the estimated CTL killing efficacies were independent
of the model for viral escape. Some escape data could not be
well described by the sequential escape model for biologically
reasonable parameters. Furthermore, explicitly taking CTL kinetics into account did not improve the quality of fit of different
models to escape data. Our results suggest that CTL kinetics in
the blood as it is currently available may bear limited information
relevant to improve description of kinetics of HIV escape from
CTL responses.

1. INTRODUCTION
In 2014, the number of people living with human immunodeficiency virus 1 (HIV-1 or simply HIV) was estimated as 36.9
million (1), with roughly 2 million new HIV infections and 1.2
million people dead of HIV-induced diseases (AIDS) (2). Cytotoxic CD8+ T lymphocyte (CTL) responses play an important
role in control of virus replication (3, 4) by modulating some
important predictors of disease progression (e.g., viral set-point
and the rate of CD4+ T cell loss (5)). Generation of HIV-specific
CD8+ T cells by vaccination is one of the current approaches in
developing HIV vaccines (6, 7). However, HIV is able to generate
mutants (termed “CTL escape mutants”) that are not recognized
by HIV-specific T cells, which may be one of the reasons for
failure of T cell based vaccines (8–10). Better understanding of
mechanisms of viral escape and principles governing CD8+ T cell
responses to HIV may allow us to evaluate in silico a potential
efficacy of T cell-based HIV vaccines.
Viral escape from CTL responses follows a somewhat predictive
pattern with more dominant (larger magnitude) CTL responses
leading to earlier viral escape (11, 12). However, not every CTL
response elicits an escape and sometimes viral mutations occur in
regions predicted to be recognized by CTLs but in the absence of
detectable response (13). To understand the timing and kinetics
of CTL escape in HIV/SIV infection, mathematical models have
been proposed previously on the dynamics of viral escape from
a single CTL response (e.g., Ref. (14–20)). These initial models
made a strong assumption of independent viral escape—i.e., it was
assumed that viruses escaping from different CTL responses do
not compete. Recent work, however, suggested presence of clonal
interference and genetic hitchhiking among immune escape variants through reconstruction of HIV whole genome haplotypes
(21), and similar concurrent CTL escapes were observed in four
HIV-infected patients (22). Clonal interference was suggested to
impact the estimates of the escape rates (23, 24). Even though
several models have been developed to describe the dynamics of
escapes from multiple CTL responses (e.g., Ref. (17, 18, 23–26)),
many of these studies involved only model simulations and did
not use information on the actual kinetics of HIV-specific CTL
responses in predicting viral escape.
Here, we explored whether including experimentally measured
CTL kinetics improves description of the viral escape data. In
doing so, we compared predictions of three alternative models
of viral escape from CTL responses such as independent escapes,
sequential escapes, and concurrent escapes. In the first model
(independent escapes), we assumed that escape from any given
CTL response occurs independently of other escapes and directly
from the wild-type, i.e., we ignored the effects of clonal interference—in essence assuming high effective population size and/or
high recombination rate. Of note, several recent experimental
papers also assumed independent escapes (11–13). In the second
model (sequential escape), we assumed that escapes from different
CTL responses occur along a defined pathway, generally set by the
sequences of escape occurrence in the data. This model assumes
strong clonal interference, which may arise at low effective population size or when recombination rate is low. Finally, in the
third model (concurrent escape), we tracked all escape variants

Frontiers in Immunology | www.frontiersin.org

2. MATERIALS AND METHODS
2.1. Experimental Data
Experimental details of patient enrollment and data collection
were described in detail previously (12, 13). In short, data from
17 patients in the Center for HIV/AIDS Vaccine Immunology
(CHAVI) infected acutely with HIV-1 (subtypes B or C) were
analyzed in great detail. All patients were infected with a single transmitted/founder (T/F) virus as determined by the single
genome amplification and sequencing (SGA/S), and there were
enough samples to accurately quantify CTL response to the whole
viral proteome. In each patient, the kinetics of virus-specific
CTL (CD8+ T cell) responses were measured using peptidestimulated IFN-γ ELISPOT assay and/or intracellular cytokine
staining (ICS) 6 months after enrollment using peptides matched
to the founder virus sequence (12, 13). For CTL responses measured by ELISPOT, the reported magnitude of the response was
the number of cells, producing IFN-γ, per 106 peripheral blood
mononuclear cells (PBMC). Multiple viruses were sequenced by
SGA/S, and all sequences were compared at cites coding for CTL
epitopes, and changes in the percentage of transmitted (wild-type)
sequences were followed over time (12). The dynamics of the HIVspecific CTL responses and viral escape from epitope-specific CTL
responses were measured longitudinally. Escape mutants were
identified as viral variants with mutations in regions recognized
by patient’s CTL responses with a reduced (or fully abrogated)
production of IFN-γ following T cell stimulation. In many cases,
mutation in a single position was responsible for the escape. In our
analysis, all viral variants, which did not have the wild-type amino
acid in the epitope region, were considered as escape variants.
Review of the virus evolution and CTL dynamics data in all
17 patients revealed some data limitations. In particular, data for
many patients lacked adequate temporal resolution to accurately
estimate virus escape rates. In the vast majority of viral escape
variants, escapes often occurred rapidly between two sequential
time points with the frequency of the escape variant jumping from
0 to 1. While previously it was suggested that such data may be
modified to provide an estimate of the escape rate (14, 15, 17), such
approaches may lead to biased parameter estimates (25). While
development of a method for unbiased estimation of escape rate
from sparse data was recently proposed (27), for this analysis,
we focused on patients CH131 and CH159 in which viral escape
rates could potentially be accurately estimated due to sufficiently
frequent sampling. While data from these patients were presented
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differ only in the rate of infectivity (that is β w ≥ β m and pw = pm )
(13), the system (2) can be simplified as

before (12), linking of escape and CTL response dynamics was not
yet performed.

2.2. Model of Viral Escape from a Single
CTL Response

dw(t)
= [(1 − µ)r(t) − δ − k]w(t),
dt
dm(t)
= [(1 − c)r(t) − δ]m(t) + µr(t)w(t),
dt

Models describing the dynamics of viral escape from a single
cytotoxic T lymphocyte (CTL) response have been developed and
adopted by different researchers (e.g., Ref. (14–18)). Here, we start
with the basic model formulated earlier (18) and extend it to viral
escape dynamics from multiple CTL responses. The model of viral
escape from a single CTL response can be extended from the basic
viral dynamics model (28) in the following way:
dT(t)
dt
dIw (t)
dt
dIm (t)
dt
dVw (t)
dt
dVm (t)
dt

where r(t) = βwcvpw T(t) is the replication rate of cells infected by
wild-type virus, and c = 1 − ββmw is the cost of the escape mutation
defined as a selection coefficient. The frequency of the escape
m(t)
variant in the whole population is given by f(t) = w(t)+m(t)
. This
is perhaps the simplest model for a viral escape from a single CTL
response. This is denoted as model 1 in the paper.

= s(T0 − T(t)) − βw T(t)Vw (t) − βm T(t)Vm (t),
= βw (1 − µ)T(t)Vw (t) − δIw (t) − kIw (t),
= βm T(t)Vm (t) + βw µT(t)Vw (t) − δIm (t),

2.3. Models of Viral Escapes from Multiple
CTL Responses

(1)

Mathematical model given in equation (3) tracks changes in densities of wild-type virus and a single variant that has escaped
recognition from a single epitope-specific CTL response. In acute
HIV infection, the virus can escape from recognition of multiple CTL responses, which are specific to several viral epitopes
(13, 33). Several models have been developed to describe the
dynamics of escapes from multiple CTL responses (e.g., Ref., (17,
18, 26)). Our model is an extension of previous models (17, 18)
incorporating mutations from wild-type virus to different viral
escapes. In contrast with previous studies, in our analyses, here,
we used experimentally measured time courses of different CTL
responses (12).
To track the dynamics of viral escape from multiple responses,
we assume that there are in total n CTL responses that control viral
growth, and virus can potentially escape from all n responses. We
use mi to denote the density of variants where i is a vector i = (i1 , i2 ,
. . ., in ) denoting the positions of n epitopes, and we define ij = 0
if there is no mutation in the jth CTL epitope and ij = 1 if there
is a mutation leading to an escape from the jth (1 ≤ j ≤ n) CTL
response. We denote the set of escape variant as I, which is i ∈ I.
The wild-type variant is then denoted as (0, 0, . . . 0).
For our analysis, we neglect recombination and backward
mutation from mutant to wild-type. We use ki , ci , and µi to denote
killing rate due to ith CTL response, cost of escape mutation from
the ith CTL response and mutation rate for the ith epitope, respectively. Due to a small rate of double mutation (34), we assume
that escape virus is generated with only one mutation in a single
generation. That is, for two escape variants mi = m(i1 ,i2 ,...,in ) and
mj = m( j1 ,j2 ,...,jn ) , we define the mutation rate M i,j from mi to
mj as µk , if and only if mj has only one more mutation at position
k than mi and all other positions are exactly same. For example,
when there are 3 CTL responses, the mutation rate from m(1,0,0)
to m(1,1,0) is µ2 , and the mutation rate from m(0,0,0) to m(1,0,1) is
0. Assuming multiplicative fitness (detailed deviation is given in
Section S2 in Supplementary Material),∏that is, the fitness cost of
a variant i = (i1 , i2 , . . ., in ) is Ci = 1 − nj=1 (1 − cj ij ). The death
rate of the escape variant i =
∑(i1 , i2 , . . ., in ) due to remaining CTL
responses is given by Ki = nj=1 kj (1 − ij ), where we assume that
killing of infected cells by different CTL responses is additive.

= pw Iw (t) − cv Vw (t),
= pm Im (t) − cv Vm (t),

where T(t) is the density of uninfected target cells; Iw (t) and Im (t)
is the density of target cells infected by the wild-type or escape
variant viruses, respectively; Vw (t) and Vm (t) is the density of
wild-type or escape variant viruses, respectively; s is the turnover
rate of uninfected target cells; T 0 is the preinfection level of
uninfected target cells; β w and β m is infection rate of wild-type or
escape variant viruses, respectively; µ is the probability of mutation from wild-type to escape mutant during reverse transcription
of viral RNA into proviral DNA; δ is the death rate of infected
cells due to viral pathogenicity; k is the killing rate of wild-type
virus infected cell due to CTL response; pw and pm is the rate
at which cells infected by wild-type or escape mutant viruses
produce viruses; and cv is the clearance rate of free viral particles.
In this model (equation (1)), we assume that target cells infected
by wild-type (Vw (t)) and escape viruses (Vm (t)) differ by two factors: viral infectivity (β w and β m ) and the rate of virus production
(pw and pm ). Given that in vivo viral particles are short-lived (29,
30), to a good approximation, we may assume a quasi steady state
for the virus particle concentration leading to V∗w (t) = pcwv Iw (t)
and V∗m (t) = pcmv Im (t). We define a fitness cost c = 1 − ββmw ppmw ,
where c can be positive or negative. Positive c means true fitness
cost of escape mutations, which is escape variant and has a lower
replication rate (β m pm ≤ β w pw ) (31), and negative c implies fitness
advantage of escape virus (31, 32). By straightforward calculation,
the system (equation (1)) can be written as
dV∗w (t)
= [(1 − µ)r(t) − δ − k]V∗w (t),
dt
dV∗m (t)
pm
= [(1 − c)r(t) − δ]V∗m (t) + µr(t)V∗w (t) .
dt
pw

(2)

For convenience, we replace V∗w (t) and V∗m (t) by w(t) or m(t),
respectively, and assume that the wild-type and escape viruses
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Similar to equation (3), the dynamics of the wild-type and
escape variants are given by




∑
dmi (t) 
= r(1 − Ci ) 1 −
Mi,j  − Ki − δ  mi (t)
dt
j∈I
∑
+
r(1 − Cj )Mj,i mj (t), i ∈ I.
(4)

Based on the available time course information of epitopespecific T cell response Ei (t), we used the first-order interpolation
function (termed as “interpolated response”) or the fitted response
function (termed as “fitted response”) by the T on –T off model
(38) to quantify the kinetics of HIV-specific CTL responses. The
T on –T off model assumes that the response starts with E0 epitopespecific CD8+ T cells that become activated at time T on . Activated
T cells start proliferating at a rate ρ and reach the peak at time T off .
After the peak, epitopes-specific CD8+ T cells decline at a rate α.
The dynamics of the CD8+ T cell response E(t) is given thus by the
following differential equation:

j∈I

∑
We define M(t) = i∈I mi as the total density of all variants
in the population, and fj (t) (j = 1, . . ., n) is the fraction of viral
variants that have escaped recognition from the jth CTL response.
The frequency of a viral variant escaping from the jth response is
given by
∑
fj (t) =
mi (t)/M(t), J = (i1 , . . . ij , . . . , in ) with ij = 1. (5)



0,
dE
= ρE,

dt

−αE,

if t < Ton ,
if Ton ≤ t ≤ Toff ,
if t > Toff

(6)

i∈J

with E(0) = E0 . Here the “precursor frequency” E0 is a generalized recruitment parameter, which combines the true precursor
frequency and the recruitment rate/time (38, 39). Our recent
work showed that this model (equation (6)) reasonably well
describes kinetics of HIV-specific CTL responses in acute HIV
infection (40). When fitting the model (equation (6)) to experimental data of CTL dynamics, we changed all initial undetected
response values from 0 to 1; the latter was the detection limit in
the data.

Based on previous work (22, 25, 35), we assume that there
are two alternative ways to generate escape mutants (Figure 1).
The first way can be called “sequential” escape (model 2), that is
escape mutants are generated sequentially along a defined path
from wild-type viruses. This is likely to happen when the effective
population size of HIV is small and when the rate of recombination is negligible. The second way can be described as “concurrent” escape (model 3), in which the virus can escape from n
CTL responses simultaneously along multiple different pathways.
This is likely to happen when the HIV effective population size
is large. With n CTL responses, there are n escape variants for
“sequential” escape and 2n − 1 escape variants for “concurrent”
escape in addition to the wild-type variant. For example, with
n = 3 CTL responses, for “sequential” escape, there are 3 escape
variants: m(1,0,0) , m(1,1,0) , and m(1,1,1) with m(0,0,0) being the wildtype virus. For “concurrent” escape, there are 7 escape variants:
m(1,0,0) , m(0,1,0) , m(0,0,1) , m(1,1,0) , m(1,0,1) , m(0,1,1) , and m(1,1,1) with
m(0,0,0) being the wild-type virus (Figure 1). Detailed equations
for both models with n = 3 CTL responses can be found in Supplement (Section S2 in Supplementary Material). It is interesting
to note that “sequential” escape is a simplification of “concurrent”
escape when the effective population size is small. Previous work
did not fully resolve whether CTL escapes in HIV infection occur
sequentially or concurrently (22, 25); most likely the type of escape
varies by patient.

2.5. Statistics
Previously, under the assumption that some mutants are present
initially, researchers (e.g., Ref. (16, 36)) fit a logistic model to
data on viral escape kinetics by the method of nonlinear least
squares (41). In essence, this is a maximum likelihood method,
which assumes normally distributed residuals. While this standard statistical method provides reasonable parameter estimates,
it assumes equal weights to different data points independently
of how many viral sequences were measured at every time point,
which is likely to be unrealistic for most experimental studies.
Here, we follow the method proposed recently (18) to use binomial distribution (and thus different weights for different measurements/time points) in the likelihood of the model given the
escape data. For HIV escape from a single CTL response, the
log-likelihood function is given by

2.4. Models for CTL Response

L=

The killing rate ki of the CTL response specific to the ith epitope
in all three models is composed of two parts: the per-cell killing
efficacy of CTLs (k′i ) and the number of epitope-specific CTLs (Ei )
(16). Previously the killing rates ki were often set to a constant
(e.g., Ref. (16, 18)), or were set to a certain form k′i g(Ei (t)) where
g(Ei (t)) is a function of epitope-specific CTL responses Ei (t) (e.g.,
Ref. (24, 36)). With the measured epitope-specific CTL response
dynamics (13), we adopted two forms of killing rate: constant ki
(termed as “constant response”) or time-dependent killing rate
k′i Ei (t) (termed as “interpolated/fitted response”). We used the
“mass-action” killing term to describe effect of CTLs on virus
dynamics because it is the simplest form, it involves minimum
parameters, and it is supported by some experimental data (37).

Frontiers in Immunology | www.frontiersin.org

Ti
∑

[aj ln( f(tj )) + (Nj − aj )ln(1 − f(tj ))],

(7)

j=1

where aj is the number of escape variant sequences in a sample of
Nj sequences at the sample time tj , Ti is the number of measured
time points for a ith specific viral escape trajectory, and f (tj )
is the predicted frequency of a specific viral escape variant at
time tj . Model parameters were thus found by maximizing the
log-likelihood function (equation (7)).
To discriminate between alternative models under different
parameter constrains, we used corrected Akaike information criterion (AIC) scores (42). The model fit with the minimum AIC
score among tested models was treated as the best model; however,
a difference of less than 3 AIC units is generally viewed as not
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FIGURE 1 | Escape paths for models 1, 2, and 3 with 3 CTL responses. For model 1, there are 3 escape variants: m(1,0,0) , m(0,1,0) , and m(0,0,1) . For model 2, there are
also 3 escape variants: m(1,0,0) , m(1,1,0) , and m(1,1,1) . For model 3, there are 7 escape variants: m(1,0,0) , m(0,1,0) , m(0,0,1) , m(1,1,0) , m(1,0,1) , m(0,1,1) , and m(1,1,1) . In each
case, m(0,0,0) is the wild-type virus.

significant (42). To test the statistical significance of the differences between parameters found by fitting different models, we
used a bootstrap approach (43). In this approach, we resampled
the data 1,000 times using the Random routine in Mathematica
assuming beta distribution for sequencing data (44), fitted models
to bootstrap samples, and recorded all estimated parameters. For
the same parameter, we use either paired and unpaired t-test to
compare the parameter averages for different models.
Both fitness costs of escape mutations and the killing efficacy
of the CTL response determine the kinetics of viral escape from
T cells (14–16), and that viral escape (sequence) data in most
cases are not sufficient to estimate both rates (16). Therefore, in
our analyses, to avoid overfitting, we set fitness cost of escape to
0 ci = 0. In all fits, we assumed that the rate of virus replication
r = 1.5/day (28).
While multiple models may be able to describe accurately
experimental data, some models may do so at biologically unreasonable parameters. For example, estimated rate of mutation at
different epitopes may be unrealistically large. Thus, in our analysis, we assume that mutation rates, which are above 10−3 are likely
to be unrealistic given that currently estimated HIV mutation rate
is about 3.2 × 10−5 per bp per generation (34) and size of a CTL
epitope is 8–10 amino acids (3 × 10 × 3.2 × 10−5 ≈ 10−3 ).
To fit the T on –T off model [equation (6)] to experimental data
using non-linear least squares, we log-transformed the model
predictions and the data.
When interpolating CTL response kinetics, there was often not
enough information on the starting point (day 0). In such situations, we set the initial CTL density as 1 (the detection level for
this data set) for simplicity. Other starting points (e.g., intersection
point of the CTL response axis and the reverse extension line of the
interpolation function) were also tested and led to similar results
(not shown). This was largely due to the fact that, in our models,
CTLs at low densities are not expected to exert large selective
pressure on the virus population due to assumed mass-action
killing term.

population. Following HIV-1 infection, the virus escapes from
several cytotoxic T lymphocyte (CTL) responses (45), and multiple studies used mathematical models of various levels of complexity to estimate the predicted efficacy at which CTLs recognize
and eliminate cells, infected with the wild-type (unescaped) virus
(14–18, 25). Many of these previous studies estimated the rate of
HIV escape from immunity using nonlinear least squares, which
explicitly assumes normal distribution of the deviations between
model predictions and data (14–17). However, the assumption of
normally distributed residuals is likely to be violated for data when
only a handful of viral genomes are sequenced—which is common in many studies involving single genome amplification and
sequencing techniques (SGA/S). We have recently proposed to use
a likelihood approach, which assumes virus genome sampling to
follow a binomial distribution (18). This binomial distributionbased likelihood approach showed to impact the estimates of the
CTL killing rate (escape rate can be proportional to the killing rate
under an assumption of constant CTL response) when compared
to normal distribution-based likelihood approach (least squares)
(18). However, this previous comparison was done on data, which
were fairly sparse and comparison involved modifications of data
to allow for non-zero and non-one frequencies of the escape
variant (14, 15), and thus, it remained unclear if estimates of
escape rates are truly dependent on the statistical model for better
sampled data.
Unfortunately, in our cohort of 17 patients (12), very few
patients were sampled frequently enough to observe gradual accumulation of escape variants in the population (i.e., data with
two sequential time points with mutant frequency in the range
0 < f < 1 were rare). For the analysis, we, therefore, used the
escape data from two patients, CH131 and CH159, where CTL
and HIV sequence measurements were sufficiently frequent to
address our modeling questions. We fitted a simple mathematical model describing escape of the virus from a single constant
(non-changing) CTL response (equation (3)) to the data from
one patient CH159 (Figure 2) assuming two different statistical
models: with normally distributed residuals (least squares) or
binomial distribution-based likelihood (equation (7)). Consistent
with our previous observation, we found that the type of statistical
model impacts the estimate of the escape rate (k in Figure 2) with
difference being nearly twofold (k = 0.27/day vs. k = 0.51/day).
It is interesting to note that, visually, the least squares method
appear to describe the data better by accurately fitting the points
with intermediate frequency of the escape variant in 20–30 days

3. RESULTS
3.1. Statistical Model Impacts Estimation
of the Escape (Killing) Rate
Given virus evolution data, we may be often interested in quantifying selecting pressures driving specific changes in the virus
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A

B

FIGURE 2 | Statistical model has a strong impact on the estimated killing rate. We fit model in equation (7) to the same data for HIV escape in the protein region
DREVLIWKFDSSLARRHL of Nef (Nef 177–194) in patient CH159, assuming normal distribution-based likelihood (normally distributed residuals or nonlinear least
squares (A)) or binomial distribution-based likelihood method (B). Data are shown as dots and bars represent the 95% confidence intervals calculated using beta
distribution (Jefferey’s intervals (44)). The fitted parameters are µ = 7.76 × 10−7 and k = 0.51 day−1 (A), or µ = 2.00 × 10−4 and k = 0.27 day−1 (B).

after the symptoms (but missing the another intermediate data
point (12, 0.08)). However, this visually better fit is not supported by the statistics: likelihood of the model for these data is
−12.64 or −10.53 for normal (Figure 2A) or binomial (Figure 2B)
distribution, respectively (and AIC scores being 31.0 vs. 26.8,
respectively). Interestingly, the main difference in the estimated
escape rates was driven by just one data point ((t, f ) = (12, 0.08));
removing this data point from the data led to identical estimates of
the escape rate, k = 0.51/day, from two statistical models (results
not shown). This is not surprising because with this data point
removed, the information on escape rate is only coming from
two data points when the frequency of the escape variant is
intermediate (0 < f < 1).
As discussed before, least squares may not allow to estimate
escape rates, e.g., in cases when mutant frequency jumps from 0
to 1 between two subsequent time points unless data are modified
(14, 15). Similarly, models assuming normally distributed residuals may not be able to fit other types of data, in which frequency
of the mutant has an intermediate value (0 < f < 1) at one time
point only. In particular, in our analysis of another escape in
patient CH159 (Rev GRPTEPVPFQLPPLERLC, see Figure 3), we
could not obtain finite estimates of the escape rate using normally
distributed residuals (results not shown). Rather, the model fits
tended to describe accurately two data points (t = 22 days and
t = 29 days) and ignore another data point (t = 56 days) leading to
extremely high predicted escape rates (results not shown). Interestingly, using binomial distribution-based likelihood allowed for
an accurate fit of the model to data and the fit compromised
between describing early and late data points (Figure 4A). The
reason for the compromise is that a fit predicting fast escape and
nearly 100% escape variant by 56 days since symptoms is highly
disfavored by the binomial distribution-based likelihood because
some wild-type variants were still present at day 56 (thus, the
weight for missing this point by the model fit was very high
in binomial distribution-based likelihood but not in the normal distribution-based likelihood). Taken together, these results
suggest that the type of the statistical model used to estimate
HIV escape rates influences the final estimates. Therefore, many
previous studies on HIV escape assuming normally distributed
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residuals may need to be re-evaluated for the robustness of their
conclusions.

3.2. CTL Response Kinetics Do Not
Improve Description of the Escape Data
As CTL responses drive HIV escape from epitope-specific T cells,
it is expected that the magnitude of the CTL response should
naturally impact escape kinetics. Previous studies provided some
evidence that the relative magnitude of a given CTL response
in the total HIV-specific CTL response early in infection (%
immunodominance) predicts the timing of viral escape (11, 12).
Immune response was also shown to impact escape of simian
immunodeficiency virus (SIV) from T cell responses (19, 46, 47).
Immune response magnitude, and as a consequence, the overall
CTL killing efficacy is important in determining both timing and
speed of viral escape with the rate of viral escape being directly
related to the immune response efficacy (16, 17). In contrast, both
initial mutant frequency, virus mutation rate, and CTL killing
efficacy determine timing of viral escape (17). Whether inclusion
of the experimentally measured CTL dynamics impacts ability of
mathematical models to accurately describe viral escape data has
not been tested.
To test the benefits of using longitudinally measured CTL
responses in describing viral escape data, we considered several
alternative models for the CTL dynamics and viral escape. Our
model 1 describes the dynamics of viral escape from each CTL
response independently. Models 2 and 3 describe escape from
multiple CTL response that occurs sequentially or concurrently,
respectively (see Materials and Methods for more details). CTL
dynamics was either considered to be unimportant (i.e., killing
rate ki was set constant over time), or when killing rate was proportional to the experimentally measured CTL frequency (k′i Ei (t)),
respectively. To describe CTL dynamics, we either used the first
order interpolation function or the T on –T off model (equation (6)
and see Materials and Methods for more detail).
In patient CH159, four CTL responses were detected
(Figure 3B), and three of these responses were escaped within
nearly 4 years of infection. Interestingly, the response specific
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FIGURE 3 | Basic dynamics of CTL response and HIV escape for patient CH159. Data are from a previous publication (12); the data show four CTL responses in the
patient (B) and frequencies of corresponding escape variants (A). Based on the selection criteria described in the Materials and Methods, we focused our analysis on
CTL dynamics and escape in two regions: Rev GRPTEPVPFQLPPLERLC (65–82) and Nef DREVLIWKFDSSLARRHL (177–194) shown for the first 200 days in panels
(C,D). Dashed lines in panel (D) are the prediction of the T on –T off model to these data with the following estimated parameters for the Rev-specific T cell response:
E 0 = 1 IFNγ + SFC/106 PBMC, T on = 12 day, T off = 29 day, ρ = 0.23 day−1 , α = 1.67 × 10−6 day−1 ; and for the Nef-specific T cell response: E 0 = 73.59
IFNγ + SFC/106 PBMC, T on = 0 day, T off = 126.05 day, ρ = 6.98 × 10−3 day−1 , α = 1.86 × 10−3 day−1 .

to Gag TPQDLNTML was dominant (Figure 3B), but the
corresponding escape mutant Gag TPQDLNTMLNTVGGHQAA
did not appear up to 1,132 days since onset of symptoms
(Figure 3A).
Patient CH159 had two escape mutants in regions
Rev GRPTEPVPFQLPPLERLC (Rev 65–82) and Nef
DREVLIWKFDSSLARRHL (Nef 177–194) satisfying our
selection criteria (Figure 3C). Despite a relative small magnitude
of CTL responses specific to Rev65 and Nef177 early in infection
(up to 29 days since onset of symptoms), escape mutants appeared
early and their frequencies arose rapidly.
We fitted three alternative mathematical models for viral escape
and three alternative models for the CTL dynamics to the data
on viral escape (Figure 3C) using binomial distribution-based
likelihood method (see Materials and Methods for more detail).
Surprisingly, we found that the models 1 and 3 with a constant
immune response described the data with best quality as judged
by the AIC (or likelihood). Parameter estimates in the model 1,
which assumes independent escape were nearly identical to the
parameters in the model 3, which assumed concurrent escape
(Figure 4; Table 1). Importantly, adding experimentally measured
CTL response dynamics (as interpolated function or by using
parameterized T on –T off model) did not improve the quality of the
model fit to escape data (Table 1). Even worse, for models 1 and
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3, the fits with a fitted response were of lower quality as judged
by the large increase in AIC (Table 1). Models that included an
interpolated CTL response provided better fits than models with
a fitted response (Table 1).
The exact reasons of why including experimentally measured
CTL response dynamics led to worse fits of the escape data are
unclear but perhaps rapid change in magnitude of CTL responses
in this patient—if response directly impacts killing of infected
cells—was simply not reflected in the kinetics of viral escape
(Figures 4D,G). Specifically, CTL kinetics-driven escape would
predict non-monotonic rise in the escape variant frequency, which
was not observed in the data, thus, favoring a model with a
constant killing rate by CTLs.
Interestingly, the model 2 fits of the data resulted in unphysiologically large estimates for the mutation rate µ2 (Table 1). As
we elaborate later (see below), this failure of the model to describe
these data stems from the fact that escapes in the data occur nearly
at the same time and assuming that escapes are sequential led to
an unrealistic mutation rate in the second epitope. This suggests
that the observed dynamics of viral escape in patient CH159 is not
consistent with sequential escape.
Models 1 and 3 also predicted slightly higher than expected
mutation rate µ1 (bigger than 10−3 ) for the peptide Rev 65–82.
Constraining this parameter to remain µ1 ≤ 10−3 led to fits of
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FIGURE 4 | Including CTL response dynamics worsened model fits of HIV escape data in patient CH159. We fitted model 1 (independent escapes, equation (3),
panels (A,D,G)), model 2 (sequential escape, equation S6 in Supplemental Material, panels (B,E,H)), and model 3 (concurrent escape, equation S8 in Supplementary
Material, panels (C,F,I)) to escape data in patient CH159 with different response inputs (constant, interpolated, or fitted response, see Materials and Methods for
more detail). Adding direct time-dependent response (interpolated or fitted response) did not improve the quality of the model fit to data (see Table 1 for parameter
estimates). Model 2 was not able to accurately describe these data for biologically reasonable mutation rates (see Table 1).

significantly lower quality (likelihood ratio test, p < 0.05). Due to
large length of the peptide, the overall mutation rate in this region
could indeed be slightly higher than our calculated high bound
for the mutation rate (see Materials and Methods for more detail).
Furthermore, since peptide Rev 65–82 is the epitope in which
first escape occurred, it was possible that the high estimate of the
mutation rate could be due to late sampling of viral sequences. In
these, data sampling was done after patients were diagnosed with
infection; however, viral escape could have started earlier and for
escapes starting earlier, it may be possible to describe the data with
a lower mutation rate (18, 48).
Therefore, to test whether the timing of the start of the escape
influences the estimate of the mutation rate we did the following.
We shifted the data for two escapes forward by adding some initial
zeroes to data and reverse extended the predicted CTL response
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curves. Then we refitted models 1 and 3 to the data under the
constrain µ ≤ 10−3 . We found shifting the data did not improve
the quality of the model fits as compared to unmodified data when
CTL dynamics is explicitly taken into account as interpolated or
fitted response (results not shown). However, assuming a constant
response allowed to obtain lower, more physiological estimates
of the mutation rate. These results suggest that inability of the
models, which explicitly incorporate CTL dynamics to explain
kinetics of first escape with physiologically reasonable mutation
rate is due to late appearance of the CTL response. Indeed, escape
can only accumulate when CTL response is present and extending
the time window for virus evolution but not having CTL response
active will not significantly impact estimates of the mutation rate.
Given our results for one patient, we next sought to investigate
whether our conclusions will remain robust when looking at
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TABLE 1 | Parameters for the three models fitted to escape data from patient CH159.
Peptide

Constant
response

Interpolated
response

Fitted
response

Rev 65–82
Nef 177–194

Rev 65–82
Nef 177–194

Rev 65–82
Nef 177–194

Model 1

Model 2

Model 3

Mutation rate
Killing rate
(µi , i = 1, 2)
(ki , i = 1, 2)
1.68 × 10−3
0.17
2.02 × 10−4
0.27
L = –25.25, AICc = 62.14

Mutation rate
Killing rate
(µi , i = 1, 2)
(ki , i = 1, 2)
9.71 × 10−4
0.20
0.11
6.29 × 10−12
L = –25.66, AICc = 62.95

Mutation rate
Killing rate
(µi , i = 1, 2)
(ki , i = 1, 2)
1.68 × 10−3
0.17
2.0 × 10−4
0.27
L = –25.25, AICc = 62.14

Mutation rate
Killing rate
(µi , i = 1, 2)
(k′i , i = 1, 2)
8.88 × 10−3
2.12 × 10−3
4.94 × 10−4
3.23 × 10−3
L = –27.21, AICc = 66.05

Mutation rate
Killing rate
(µi , i = 1, 2)
(k′i , i = 1, 2)
1.64 × 10−3
2.03 × 10−10
697.77
2.32 × 10−3
L = –26. 10, AICc = 63.84

Mutation rate
Killing rate
(µi , i = 1, 2)
(k′i , i = 1, 2)
8.88 × 10−3
2.12 × 10−3
4.93 × 10−4
3.23 × 10−3
L = –27. 21, AICc = 66.05

Mutation rate
Killing rate
(µi , i = 1, 2)
(k′i , i = 1, 2)
1.43 × 10−2
1.39 × 10−3
2.46 × 10−4
3.25 × 10−3
L = –29.68, AICc = 70.99

Mutation rate
Killing rate
(µi , i = 1, 2)
(k′i , i = 1, 2)
1.13 × 10−3
8.50 × 10−18
13,004.84
2.29 × 10−3
L = –26.61, AICc = 64.86

Mutation rate
Killing rate
(µi , i = 1, 2)
(k′i , i = 1, 2)
1.43 × 10−2
1.39 × 10−3
2.47 × 10−4
3.25 × 10−3
L = –29.68, AICc = 70.99

Fits of the model to data are shown in Figure 4. L and AICc are the log-likelihood and the corrected Akaike information criterion value, respectively. In bold, we show maximum L and
minimum AICc reached by the models 1 and 3 with constant response. There are some unrealistic mutation rates given by model 2 (much bigger than 10−3 , highlighted as italic), and
models 1 and 3 also led to slightly unrealistic mutation rates at the peptide Rev 65–82 (slightly bigger than 10−3 ). Units for ki and k′i are day−1 and µi is dimensionless (same for all
tables below).

data from another patient. Patient CH131 had 6 CTL responses,
and there was escape from at least 5 of these responses in
2 years since symptoms (Figure 5). One escape, Nef EEVGFPVKPQV (Nef 64–74), occurred very early in infection, and
two escapes, Env RQGYSPLSFQTLIPNPRG (Env 709–726) and
Gag VKVIEEKAFSPEVIPMFT (Gag 156–173), occurred late
(Figure 5). In this patient, the pattern of escape followed the
ranking of immunodominance of CTL responses (12): Nef64specific CTLs were dominant at symptoms and drove earlier
escape, while Env 709- and Gag156-specific CTLs arose later with
escapes occurring later in infection (Figures 5A,B). However,
there were apparently discrepancies such as two escapes in Tat
epitopes (Tat DPWNHPGSQPKTACNNCY, that is Tat 9–26 and
Tat FQKKGLGISY, that is Tat 38–47) occurred at the same time
while CTL responses specific to these different epitopes were
of different sizes (Figures 5A,B). Because escapes in these two
Tat epitopes occurred rapidly and did not have two intermediate
measurements of the mutant frequency, our following analysis was
only restricted to escapes in three CTL epitopes: Nef64, Env709,
Gag156 (Figures 5C,D).
We thus fitted 3 different models of viral escape combined with
3 different models for the CTL dynamics to the data on viral escape
(Figure 6). Importantly, as with the analysis of data from patient
CH159, we found that including the data-driven CTL dynamics
in the escape models did not improve the quality of the model
fit to the escape data (Table 2). In contrast with the previous
results, though, the assumption of the constant and time-variable
killing efficacy (i.e., due to variation in the immune response
magnitude) did not strongly impact the quality of the model fit as
judged by the AIC or likelihood (Table 2). Importantly, however,
models 1 and 3 gave nearly identical estimates of the CTL killing
efficacy, suggesting that for data with good temporal resolution
model estimates of the CTL killing efficacy (or by inference, escape
rates) are not strongly dependent on the specific mechanisms
used to describe escape (independent vs. concurrent escape). This
observation also suggests that exclusion of the data on escape
occurring at intermediate times after symptoms in Tat should not
Frontiers in Immunology | www.frontiersin.org

influence the accuracy of estimation of the killing rates of CTLs
specific to other epitopes in CH131.
Extending the observation made with the patient CH159 data,
we found that model assuming sequential escape (model 2) could
not accurately describe the dynamics of viral escape for biologically reasonable parameter values specifically for the third
escape in Gag156 although this inability was significant only for
a constant killing efficacy (Table 2). Allowing time-dependent
killing efficacy resulted in small yet larger values for the mutation
rate than that expected from basic calculations. Forcing the
mutation rate µ3 to be constrained (µ3 ≤ 10−3 ) significantly
reduced the quality of the model fit to data (likelihood ratio test,
p ≪ 0.001). Furthermore, estimates for the CTL killing efficacy
differed between model 2 and models 1 and 3 suggesting that
model choice (sequential vs. concurrent) may indeed influence
estimates of the killing efficacy.

3.3. No Difference in Predicted Killing
Efficacy of CTLs, Specific to Different
Epitopes
Our analyses, so far, demonstrated that several different mathematical models were capable of accurately describing the escape
data, but this ability was dependent on the specific pathway of how
escape mutants were generated and the assumption on whether
data-driven CTL dynamics was included in the model. In cases,
when a model was able to accurately describe the data, we generally observed different estimates for the parameters for HIV
escape in different epitopes; for example, for the data in patient
CH131 estimated CTL killing rate in the model 1 (independent escapes) with interpolated response different nearly 100-fold
between k′1 and k′3 (Table 2). Knowing which immune responses
may be more efficient on a per cell basis in killing virus-infected
cells may be beneficial for inducing such responses by vaccination.
We, therefore, investigated how robust these differences in estimated per capita killing rates are. For that, we fitted mathematical
models assuming equal killing efficacies to the data on escape.
9
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FIGURE 5 | Basic dynamics of CTL response and HIV escape in patient CH131. Patient CH131 had 6 CTL responses (B) and 5 responses were escaped by
700 days since infection (A). Based on our selection criteria (see Materials and Methods), we focused our analysis on escape in three epitopes: Nef 64–74, Env
709–726, and Gag 156–173 (C) with the corresponding CTL dynamics (D). Dashed lines in panel (D) denote fits of the T on –T off model (equation (6)) to these data
resulting in the following estimates for the model parameters for Nef-specific T cell responses: E 0 = 808.59 IFNγ + SFC/106 PBMC, α = 4.55 × 10−3 day−1 ; for
Env-specific T cell responses: E 0 = 82.97 IFNγ + SFC/106 PBMC, T on = 0 day, T off = 202.02 day, ρ = 0.017 day−1 , α = 9.23 × 10−3 day−1 ; for Gag-specific T cell
responses: E 0 = 1.67 IFNγ + SFC/106 PBMC, T on = 0 day, T off = 80.76 day, ρ = 0.084 day−1 , α = −1.04 × 10−3 day−1 .

As expected, reducing the number of fitted parameters led to fits
of lower quality (as judged by the log-likelihood); however, this
reduction in complexity of the model was favored by the AIC
and in most cases by the likelihood ratio test (Tables S2 and S4
in Supplementary Material). Visually, the reduction in the quality
of the model fit to data was also relatively small (Figures S2 and
S4 in Supplementary Material). Thus, for these data, we found no
strong evidence in the difference in the estimated per capita killing
efficacy of the CTL response specific to different viral epitopes.

close to each other, which naturally required a high mutation rate
from one variant to another. Therefore, only when trajectories are
separated in time mutation rate µ2 is expected to be biologically
reasonable. Indeed, by simulating virus dynamics using model
for sequential escapes by varying model parameters, we found
that CTL killing rate has the major impact on the time delay
between two escapes (Figure 7). This analysis thus suggested that
for the model 2 (sequential escape) to be consistent with the data,
escapes from 2 responses must be separated in time by about
20–50 days.

3.4. Identifying Conditions When the Model
2 (Sequential Escapes) Fails

4. DISCUSSION

In analysis of data from both patients, we found that model 2,
describing sequential escape from CTL responses, was not able
to accurately describe experimental data for biologically reasonable parameter values; these model fits predicted extremely high
mutation rates (e.g., see Tables 1 and 2). Additional analyses
demonstrated that fitting the models with constrained mutation
rates, µi ≤ 10−3 led to fits of significantly lower quality (based on
increased AIC, results not shown).
A closer look at the experimental data for which model 2
provided unreasonably high mutation rates revealed that the
trajectories of two subsequent escapes in the model 2 were too
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CTL responses play a major role in HIV within-host evolution (45,
49). Recent studies suggested that a relative magnitude of the CTL
response (relative immunodominance) plays an important role in
determining the time of viral escape from T cell responses (11, 12).
These previous studies, however, only utilized a maximum value
of the CTL response early in infection, in general, within 50 days
since the onset of symptoms, and thus impact of the kinetics of
CTL response on the rate of virus escape remained undetermined.
Furthermore, the pathways of HIV escape from CTL responses
were not fully resolved as escapes occurring sequentially and
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FIGURE 6 | Including CTL response dynamics did not improve model fits of HIV escape data in patient CH131. We fitted model 1 (independent escapes, panels
(A,D,G)), model 2 (sequential escape, panels (B,E,H)), and model 3 (concurrent escape, panels (C,F,I)) to escape data in patient CH131 with different CTL response
inputs (constant, interpolated, or fitted response). Adding data-derived time-dependent CTL response (interpolated or fitted response) does not improve the fitting
results in most cases (Table 2). Notably, model 2 was unable to accurately describe late escape for biologically reasonable mutation rate µ3 . Model parameters
providing the best fit are given in Table 2.

concurrently have been proposed (21, 22, 25), and several previous
studies assumed that escapes occur independently from each other
(14, 15, 17). Here, by using experimental data on evolution of HIV
sequences from acute infection into chronic phase and temporally
resolved dynamics of HIV-specific CTL responses, we tested the
hypothesis that CTL dynamics plays an important role in virus
escape.
Perhaps, in contrast with our initial expectations (e.g., due to
Ref. (11, 50)), we found that including experimentally measured
dynamics of epitope-specific CTL responses did not lead to a
better description of the kinetics of viral escape from T cells (e.g.,
in patient CH131, Table 2), or even reduced the quality of the
model for viral escape fit to data (e.g., in patient CH159, Table 1).
This was not because we assumed that killing of virus-infected
cells was dependent on the absolute magnitude of epitope-specific
CTL responses; assuming frequency-dependent killing, that is,
when killing
∑ of infected cells expressing ith epitope was given by
ki Ei (t)/ nj=1 Ej (t) (1 ≤ i ≤ n), led to similar conclusions (results
not shown). Because previous work suggested that kinetics of
Frontiers in Immunology | www.frontiersin.org

escape was independent of the specific mechanism of how CTLs
suppress wild-type virus (e.g., killing of infected cells or virus
production by infected cells) (16), we did not investigate nonlytic control of HIV by T cells. It is interesting that the lack of
correlation between the rate of viral escape and CTL response
magnitude was highlighted previously (17).
Reasons of why a model with time-variable CTL response
did not describe experimental data better than a model with a
constant response remain unclear but several hypotheses could
be generated. First, frequency of sampling of the viral sequences
may not be high enough to detect change in the speed at which
mutant viruses accumulate in the population. Indeed, in mathematical models, CTL dynamics has a direct impact on the rate of
escape (e.g., see equation (3)), and the observed changes in CTL
densities may not be reflected in escape data if measurements are
infrequent. Second, virus sequence data could simply be noisy.
Because only handful of viral sequences were analyzed by the
SGA/S, measurements of frequencies of viral variants have in
general large expected error (e.g., Figure 2). Third, CTL dynamics
11
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TABLE 2 | Parameters estimated by fitting different models of viral escape to escape data in patient CH131 assuming constant killing rates ki (panels A–C), or time-varying
killing rates due to interpolated CTL response (panels D–E) or CTL response in the T on –T off model (panels G–I).
Peptide

Constant
response

Interpolated
response

Fitted
response

Nef 64–74
Env 709–726
Gag 156–173

Nef 64–74
Env 709–726
Gag 156–173

Nef 64–74
Env 709–726
Gag 156–173

Model 1

Model 2

Model 3

Mutation rate
Killing rate
(µi , i = 1, 2, 3)
(ki , i = 1, 2, 3)
1.75 × 10−3
0.25
1.03 × 10−7
0.031
1.49 × 10−4
5.16 × 10−3
L = –34.09, AICc = 84.38

Mutation rate
Killing rate
(µi , i = 1, 2, 3)
(ki , i = 1, 2, 3)
1.72 × 10−3
0.25
3.18 × 10−5
5.45 × 10−3
433,780.63
0.010
L = –36.54, AICc = 89.27

Mutation rate
Killing rate
(µi , i = 1, 2, 3)
(ki , i = 1, 2, 3)
1.78 × 10−3
0.25
9.91 × 10−7
0.031
1.49 × 10−4
5.19 × 10− 3
L = –34.09, AICc = 84.38

Mutation rate
Killing rate
(µi , i = 1, 2, 3)
(k′i , i = 1, 2, 3)
4.33 × 10−4
1.97 × 10−4
−6
7.07 × 10
3.01 × 10−5
1.56 × 10−4
4.59 × 10−6
L = –34.02, AICc = 84.24

Mutation rate
Killing rate
(µi , i = 1, 2, 3)
(k′i , i = 1, 2, 3)
3.95 × 10−4
2.00 × 10−4
−5
8.76 × 10
1.56 × 10−5
3.33 × 10−3
7.48 × 10− 14
L = –36.79, AICc = 89.77

Mutation rate
Killing rate
(µi , i = 1, 2, 3)
(k′i , i = 1, 2, 3)
4.30 × 10− 4
1.96 × 10− 4
−6
7.17 × 10
3.00 × 10− 5
1.55 × 10− 4
4.61 × 10− 6
L = –34.02, AICc = 84.24

Mutation rate
Killing rate
(µi , i = 1, 2, 3)
(k′i , i = 1, 2, 3)
3.25 × 10−3
3.38 × 10−4
1.38 × 10−6
2.59 × 10−5
1.73 × 10−4
2.82 × 10−6
L = –33.94, AICc = 84.07

Mutation rate
Killing rate
(µi , i = 1, 2, 3)
(k′i , i = 1, 2, 3)
2.99 × 10−3
3.46 × 10−4
8.90 × 10−5
1.05 × 10−5
3.41 × 10−3
6.90 × 10− 14
L = –36.98, AICc = 90.17

Mutation rate
Killing rate
(µi , i = 1, 2, 3)
(k′i , i = 1, 2, 3)
3.16 × 10−3
3.41 × 10− 4
1.12 × 10−6
2.66 × 10− 5
1.73 × 10−4
2.83 × 10− 6
L = –33.94, AICc = 84.07

Alternative models assume independent escape (model 1, panels A, D, and G), sequential escape (model 2, panels B, E, and H), or concurrent escape (model 3, panels C, F, and I). Fits
of models 1 and 3 gave very close parameter values, but there were some unrealistic parameter values (italicized in the table) from fits of the model 2. L and AICc give the log-likelihood
score and the correlated Akaike information criterion value, respectively. Models 1 and 3 fit almost equally with three types of response inputs and the lowest L and AICc are shown in
bold.

A

B

FIGURE 7 | Model, assuming sequential escape (model 2), can be consistent with escape data when the trajectories for two sequential viral escape are separated in
time. We illustrate that separation of trajectories by ∆t50 = 409.8 − 344.2 ≃ 66 days is sufficient for the mutation rate to be realistically small (A). Here, ti50 is the time
by which the ith variant reaches 50% of the viral population, so, ∆t50 = t250 − t150 . Parameters used in simulations are µ1 = µ2 = 10−5A , k 1 = k 2 = 0.02 day−1A ,
r = 1.5 day−1 , δ = 1 day−1 . The distance between trajectories needed for small predicted mutation rates is reduced for higher CTL killing rates (B) and the time is
only weakly dependent on the mutation rate assumed in simulations.

in the blood may not reflect CTL dynamics in tissues such as
secondary lymphoid organs (lymph nodes and spleen). While it is
well known that T cells recirculate in the body (51), how quickly
CTLs in the tissues migrate into the blood and then back to the
tissues during HIV infection is not known. Finally, it is possible
that the measured CTL responses were not the drivers of escape.
While the ability of CTLs to recognize the wild-type virus and
inability of the same CTLs to recognize mutant viruses is generally
interpreted as evidence that these CTLs drove viral escape, such
observations are correlational in nature, and thus cannot fully
establish the causality of escape, at least in humans.
Our results may be interpreted as contradictory to several
previous studies that found a strong correlation between the time
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of viral escape (time when an escape variant reaches frequency
of 50% in the viral population) and a relative magnitude of
CTL response (relative or “vertical” immunodominance) (11, 12).
However, our studies are not directly compatible because this
previous work focused on the timing of escape while we primarily focused on the rate of viral escape. These two parameters are differently impacted by the CTL response (17) and may
have different clinical importance. In our simple mathematical
model (e.g., equation (3)), CTL response magnitude is expected to
directly impact the rate at which an escape mutant accumulates in
the population, independently of when this escape may occur. In
contrast, timing of viral escape also depends on the mutation rate.
Biologically, however, timing of escape may be more important
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than the rate because it may be more beneficial to the patient if
viral escape occurs 5 years after infection but rapidly as compared
to slow escape in just 1 year. This conjecture clearly depends on the
premise that HIV escapes from CTL responses are detrimental to
patients.
In our analysis, we generally found that for well sampled data,
the pathway of generation of escape mutants played a minor
role in predicting overall CTL killing efficacy; assuming escapes
that occur independently (model 1) or concurrently (model 3)
gave nearly identical estimates of the CTL killing efficacy (e.g.,
Tables 1 and 2). In contrast, the model assuming sequential
escape (model 2) often failed to accurately explain experimental
data; this was due to some escapes co-occurring at nearly the
same time, which obviously violated the model assumption of
sequential escape. This inability of the sequential escape model
to describe the data may be the result of the way we compared
models to data: by using deterministic model approach and by
ignoring recombination. Using deterministic model may be justified because, in acute infection, the effective population size of
HIV may be sufficiently large and ignoring recombination may
again be appropriate because very few cells in HIV infection are
generally infected by 2 or more viruses (52, 53). However, further
work is needed to demonstrate whether our conclusions regarding
inability of sequential escape model to accurately explain some
escape data is due to some of the assumptions made in the model
by running stochastic simulations and by allowing some degree of
recombination.
Many of our model fits predicted a high mutation rate for
the first epitope to be escaped by the virus (e.g., Table 2). This
model prediction could not be changed by shifting the experimental data to allow for more time to generate escape mutant;
in part, this test failed because in the absence of epitope-specific
T cells escape variants accumulate rather slowly mainly driven
by mutations. It may indicate that immune pressure on the virus
population starts much earlier than it is reflected in the blood,
echoing our concerns of whether CTL dynamics in the blood
is an accurate reflection of T cell response in lymphoid tissues.
Currently, it is believed that lymphoid tissues and not the blood
are the major places of interactions between the virus and CTLs
(50, 54).
Our analysis further highlights the importance of choosing
the appropriate statistical model for the analysis of the escape
data–assuming normally distributed residuals, and therefore,
using least squares approach, may not be appropriate for some
escape data with very few sequences analyzed. Importantly, we
confirm that the type of statistical model has an impact on the
estimate of the escape rate (18).
We found that experimental data on HIV escape can be
explained well if we assume identical per capital killing efficacy
of CTLs, specific to different viral epitopes. This suggests that
individual per capita killing rates not accurately estimated from
these data. While it is possible that this result was the consequence
of assuming additive killing of virus-infected cells by different

CTL responses, we currently do not have any in vivo data to
support more complex killing terms.
Overall, analyses of data from two patients suggested that
models assuming independent escape of HIV from different
CTL responses (model 1) or models assuming concurrent escape
from multiple CTL responses (model 3) fit the data well and
provide very similar (often nearly identical) estimates for the
killing efficacy of CTL response. Thus, for well sampled data,
assumption of independent escapes may be sufficient to accurately estimate HIV escape rates. Also, the model with datadriven time-dependent CTL response (interpolated or fitted
response input) did not improve the quality of the model fit
to data, so, at present, it appears to be unnecessary to incorporate the experimentally measured CTL response dynamics in
the model describing viral escapes. Yet, because our results were
found only for two patients, whether similar conclusions will
be reached in other studies/patients remains to be determined.
Our analysis nevertheless demonstrates how mathematical modeling may help to quantify HIV evolution in presence of CTL
responses and to highlight potential limitations with experimental
measurements.
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